Register

Browse Companies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
0 1 2 3 4 5 6 7 8 9
Top 10 Penny Stocks
Symbol: Price: Chg %: Volume:
PEII 0.0002 0 314096159
UNGS 0.0002 -5000 312706549
KGET 0.0002 -3333 142022187
PWEI 0.0002 0 68671609
TXTM 0.0002 0 51707165
PLKD 0.0002 -3333 45516459
IDGC 0.0002 0 39314954
FFFC 0.0002 0 34700000
NSAV 0.0002 -3333 29611360
FOGC 0.0002 0 28214668
SLRW 0.0002 0 23000079
DKGR 0.0002 0 20678889
OTHM 0.0002 0 17634905
HRDN 0.0002 0 15036260
HRDN 0.0002 0 15036260
TADF 0.0002 0 12042000
MJWL 0.0002 0 11950000
YTRV 0.0002 0 11849998
DKAM 0.0002 0 11789398
PPJE 0.0002 -0 7850000
CCTR 0.0002 0 6569996
NNSR 0.0002 0 6202085
DNAD 0.0002 0 5040000
FLST 0.0002 0 3602599
PIHN 0.0002 0 2512000
OPMG 0.0002 0 2470950
UNVC 0.0002 0 2200000
UNQT 0.0002 0 2000000
AVTI 0.0002 0 1943333
INAR 0.0002 0 1870000

0001 Stocks

Sort By: Date Alphabetically

MultiCell Technologies, Inc. (MCET) Loses Momentum After Recent Climb

Thumbnail
MultiCell Technologies, Inc. (MCET) spiked last Monday after a press release came out, announcing the company had been granted a U.S. patent covering novel drug compositions and platform technologies used for fighting virus infection and cancer. MCET climbed by 57% in price on a 750 thousand share volume at a $846,1 thousand trade value. These were the highest numbers for the company in over five months and the first significant increase since late March. The next day, however, the ticker suffered... more

Bergio International, Inc. (BRGO) Files 10-Q To Report No Progress

Thumbnail
On Thursday, Bergio International, Inc. (BRGO) managed to timely submit its 10-Q for the period ended June 30, 2014. The next day, BRGO issued a press release in which it commented on the results from the report. As can be seen in the filing, the financials did not account for much progress made by the company: Cash: $65,1 thousand Total current assets: $2,1 million Total current liabilities: $879,1 thousand Revenues: $361,1 thousand Net loss: $580,1 thousand In the press release from August 15, BRGO... more

Puramed Bioscience, Inc. (PMBS) Back To Triple Zero Bottom

Thumbnail
Puramed Bioscience, Inc. (PMBS) ended last week with a slide down, lowering the price back to the $0.0001 mark. PMBS's efforts have had no success in maintaining a long-lasting interest in the company. The price of PMBS' stock has been low throughout recent events. The announcements about the company's plans for future development have been insufficient to halt the decline. PMBS' downfall began after an 8-K issued on July 11 reported about a number of decisions that shareholders seemingly did not approve... more

mPhase Technologies, Inc. (XDSL) Sinks Further Down

Thumbnail
The efforts mPhase Technologies, Inc. (XDSL) has made to attract investors' interest lately have had no reaction on the market. XDSL recently reported a growth in revenues in the last quarter of its fiscal year ended June 30, 2014. The company stated in a press release issued on August 5 that its revenues have grown by approximately 6% compared to the previous quarter. We can take a look at XDSL's 10-Q for the period ended March 31, 2014 to see what this would translate into: Cash: $87,4 thousand Total... more
First 1 2 3 4 5 6 7 8 9 10 >> Last